The Market Does Not Care About The Coronavirus. Yet.

By: Spencer Israel

Save for a couple of hiccups, U.S. stocks have spent the vast majority of the last decade steadily marching higher. But you’d be forgiven for having questioned the strength of this rally at some point.

In the last few years alone, investors have sounded the alarm over a number of headlines that were thought to be warning signs of an impending recession or market crash. To name a few: rising interest rates, slower manufacturing, a nuclear war, trade war, and multiple inverted yield curves.

Yet, in spite of those fears, U.S. stocks have consistently outperformed most other asset classes. This rally in the face of oftentimes significant headwinds has been characterized as the market climbing “a wall of worry.”

The latest of these worries is the Coronavirus. If the past few weeks have shown us anything, it’s that the market seems content to keep marching on.

An Abbreviated Timeline Of Events:
December 31: Chinese authorities first report to the World Health Organization that a type of pneumonia had been spreading since December 12 in Wuhan, a coastal city of 11 million people. Confirmed cases: 40; Confirmed deaths: 0

January 11: China announces the first confirmed death from the virus, at this point confirmed to be a different bacterial strain from SARS or MERS. Confirmed cases: 41; Confirmed deaths: 1

January 21: The CDC confirms the first case of Coronavirus in the U.S. Confirmed cases: 547; Confirmed deaths: 17.

January 30: The WHO declares a global health emergency as new countries continue to report confirmed cases of the virus. Confirmed cases: almost 8,000; Confirmed deaths: 170

February 9: The outbreak surpasses the 2002-2003 SARS epidemic. Confirmed cases: over 37,000; Confirmed deaths: 811

According to data compiled by a Coronavirus tracker set up by researchers at Johns Hopkins, there are 175 confirmed cases of Coronavirus outside of China, though only one of those has resulted in a death. The worldwide death toll as of February 12 is 1,115.

The Overall Market Seems Unconcerned…
The outbreak has roiled Chinese markets, with the Shanghai Composite Index down 5% this year while the Hong Kong Hang Seng Index is down 1.5%.

The same can’t be said outside of China. Japan’s Nikkei is up 0.86% on the year. The FTSE 100 in London is essentially flat, down 0.10%.

In the U.S., the S&P 500 is up 4% with most of those gains coming in February. That strength may be the best “wall of worry” example in recent memory, as the market is giving a loud-and-clear signal that, at least in the U.S., the Coronavirus is a temporary headwind.

…But Individual Stocks Are Volatile
However, that doesn’t mean that the effects of the virus haven’t been felt.

Investors have been selling U.S. companies with high exposure to China and global travel. Carnival Cruise Lines (down 15%), Royal Caribbean (down 15%), and Norweigan Cruise Lines (down 10%) have all been hit hard this year. And the closure of Macau has also impacted casino stocks like Wynn Resorts (down 5%) and MGM Resorts (down 1.6%).

Other travel stocks like Marriott (down 2.8%) and TripAdvisor (down 1.8%) have been relatively weak to the rest of S&P 500.

The effects haven’t been totally negative for stocks with exposure to the virus. Many micro and small-cap names have been especially volatile to announcements related to the treatment or containment of the disease. This includes biotech companies Co-Diagnostics (CODX)—which is up 264% this year—Cleveland BioLabs (CBLI)—up 263%—and medical apparel companies like Alpha Pro Tech (APT)—up 52%—and Lakeland Industries (LAKE)—up 14%.

What They’ve Said
Though many statements have been made as to the long-term effect of the Coronavirus on business, the general consensus seems to be that it’s too soon to tell.

A number of top CEO’s have addressed the virus on their earnings calls, but companies have thus far been hesitant to provide concrete forecasts on the impact it could have on their businesses. Everybody from Apple to Disney to Starbucks has announced closures until the virus gets under control. But without forward-looking statements on the financial impact to lean on, investors have largely ignored them.

Fed Chair Jerome Powell told Congress that there will “very likely” be an impact on the U.S. economy, though he was unwilling to provide a more detailed assessment other than to say that they believe the U.S. economy is still in a good place. White House Trade Advisor Peter Navarro was also uncertain as to the virus’ effect.

The most notable economic forecasts thus far have come from Moody’s Analytics and Barclays, both of whom estimate the virus will lower global GDP by 0.3% this year.

For now, there seems to be too many questions about the epidemiology of the virus and too few answers. The bull case remains that any economic effects of the virus will be short-lived. And to the bears, the market is either ignorant of the virus, arrogant, or both.

All data and figures in this article are as of February 12, 2020. The author is long Apple, Starbucks, Disney, Royal Caribbean, Norwegian Cruise Lines, Carnival, MGM, Wynn, and TripAdvisor in his 401(k).

Active Trading with Lightspeed
Lightspeed, a division of Lime Brokerage, provides active traders with all the tools required to help them find success in stock trading, and we have been developing and honing our active trader platform to offer an optimal user experience. With the intuitive interface layouts and institutional quality stock and options scanners, we aim to help traders reach their goals, no matter what their strategy is. We also offer our clients some of the lowest trading fees in the industry.

For more information on a professional trading platform with Lightspeed, please call us at 1-888-577-3123, request a demo or to open an account.

Lime Brokerage LLC is not affiliated with these service providers. Data, information, and material (“content”) is provided for informational and educational purposes only. This content neither is, nor should be construed as an offer, solicitation, or recommendation to buy or sell any securities. Any investment decisions made by the user through the use of such content is solely based on the users independent analysis taking into consideration your financial circumstances, investment objectives, and risk tolerance. Lime Brokerage LLC does not endorse, offer or recommend any of the services nor information provided by any of the above service providers and any service or information used to execute any trading strategies are solely based on the independent analysis of the user.

You may also be interested in...

Lightspeed Trader Platform Maintains Stride with Market Volatility
Read More
Market Volatility Underscores The Need For Reliable Brokerage Technology
Read More
Headline Risk Making You Sick? Here Are The Companies That Have Warned Of A Drop In Sales Due To Coronavirus
Read More
The IPOX® Week, February 24, 2020
Read More

Try the demo

Compare Platforms
Check the background of this firm on FINRA's BrokerCheck

Our website uses cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site in our Privacy Policy. By clicking OK, you agree to allow us to collect information through cookies.

OK